Eur Rev Med Pharmacol Sci 2022; 26 (4): 1268-1282
DOI: 10.26355/eurrev_202202_28120

Autophagy-regulating microRNAs: two-sided coin in the therapies of breast cancer

N. Shekari, M. Asadi, M. Akbari, B. Baradaran, H. Zarredar, F. Mohaddes-Gharamaleki, A. Anvarnia, A. Baghbanzadeh, D. Shanehbandi

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. shanebandid@tbzmed.ac.ir


Despite recent advances in the treatment of breast cancer (BC), it still remains as a prevalent and deadly cancer in the world. Given that BC is a heterogeneous disease, it is necessary to clarify molecular mechanisms in tumor cells to improve various therapy outcomes and overcome therapy resistance. Autophagy represents one of the most important intracellular degradation pathways involved in diverse biological processes and plays an important bi-directional role in tumor formation and progression. Among the several mechanisms that affect autophagy, microRNAs (miRNAs) play a crucial role as gene regulators. Several in vivo and in vitro studies have reported multiple miRNAs regulating autophagy in BC that affect tumor initiation, progression, and response to various therapies. In the present review, we highlighted the mechanisms through which miRNAs regulate autophagy in BC and their potential use as therapeutic targets.
Free PDF Download

To cite this article

N. Shekari, M. Asadi, M. Akbari, B. Baradaran, H. Zarredar, F. Mohaddes-Gharamaleki, A. Anvarnia, A. Baghbanzadeh, D. Shanehbandi
Autophagy-regulating microRNAs: two-sided coin in the therapies of breast cancer

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 4
Pages: 1268-1282
DOI: 10.26355/eurrev_202202_28120